Company Filing History:
Years Active: 2024
Title: Innovations of Fernando Garces in Cancer Treatment
Introduction
Fernando Garces is an accomplished inventor based in Sherman Oaks, California. He has made significant contributions to the field of cancer treatment through his innovative work in antibody constructs. His research focuses on developing targeted therapies that can improve patient outcomes in the fight against solid tumors.
Latest Patents
Garces holds a patent for "Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors." This invention relates to a human agonistic CD40 multispecific antibody construct designed to treat solid tumors by specifically targeting the CD40 pathway on tumor-associated antigen-presenting cells (APCs), while avoiding systemic CD40 activation. This innovative approach has the potential to enhance the efficacy of cancer therapies.
Career Highlights
Fernando Garces is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His work at Amgen has allowed him to collaborate with some of the brightest minds in the industry, further advancing his research and contributions to cancer treatment.
Collaborations
Garces has worked alongside talented colleagues such as Xin Yu and Jackson Egen. Their collaborative efforts have played a crucial role in the development of groundbreaking therapies aimed at improving cancer treatment.
Conclusion
Fernando Garces is a notable inventor whose work in developing targeted antibody constructs represents a significant advancement in cancer treatment. His innovative approach and dedication to research continue to inspire progress in the field.